Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer
Chengde Wang(Wenzhou Medical University), Hui Tian(Johnson & Johnson (United States))
Cited by 21
Related Papers
Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway
|Cell Death and Disease|2020|174
Retinoblastoma Binding Protein 2 (RBP2) Promotes HIF-1α–VEGF-Induced Angiogenesis of Non-Small Cell Lung Cancer via the Akt Pathway
|PLoS ONE|2014|37
Yes-associated protein regulates the growth of human non-small cell lung cancer in response to matrix stiffness
|Molecular Medicine Reports|2015|34